Scrambling of the amino acids within the transmembrane domain of Vpu results in a simian-human immunodeficiency virus (SHIVTM) that is less pathogenic for pig-tailed macaques

Cordes, 2001, The structure of the HIV-1 Vpu ion channel: modelling and simulation studies, Biochim. Biophys. Acta, 1512, 291, 10.1016/S0005-2736(01)00332-7

Ewart, 1996, The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels, J. Virol., 70, 7108, 10.1128/JVI.70.10.7108-7115.1996

Ewart, 2002, Amiloride derivatives block ion channel activity and enhancement of virus-like particle budding caused by HIV-1 protein Vpu, Eur. Biophys. J., 31, 26, 10.1007/s002490100177

Ewart, 2004, Potential new anti-human immunodeficiency virus type 1 compounds depress virus replication in cultured human macrophages, Antimicrob. Agents Chemother., 48, 2325, 10.1128/AAC.48.6.2325-2330.2004

Fujita, 1997, Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors, J. Gen. Virol., 78, 619, 10.1099/0022-1317-78-3-619

Goldsmith, 1995, Dissociation of the CD4 down-regulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef, J. Virol., 69, 4112, 10.1128/JVI.69.7.4112-4121.1995

Grice, 1997, Ion channels formed by HIV-1 Vpu: a modelling and simulation study, FEBS Lett., 405, 299, 10.1016/S0014-5793(97)00198-1

Hofmann-Lehmann, 2000, Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems, AIDS Res. Hum. Retroviruses, 16, 1247, 10.1089/08892220050117014

Hout, 2004, Vpu: A multifunctional protein that enhances the pathogenesis of human immunodeficiency virus type 1, Cur. HIV-1 Res., 2, 255, 10.2174/1570162043351246

Joag, 1994, Pathogenesis of SIVmac infection in Chinese and Indian rhesus macaques: effects of splenectomy on virus burden, Virology, 200, 436, 10.1006/viro.1994.1207

Joag, 1996, Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques, J. Virol., 70, 3189, 10.1128/JVI.70.5.3189-3197.1996

Klimkait, 1990, The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release, J. Virol., 64, 621, 10.1128/JVI.64.2.621-629.1990

Liu, 1999, Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques, Virology, 260, 295, 10.1006/viro.1999.9812

Luciw, 1999, Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques, Virology, 263, 112, 10.1006/viro.1999.9908

Maldarelli, 1993, Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein, J. Virol., 67, 5056, 10.1128/JVI.67.8.5056-5061.1993

McCormick-Davis, 2000, Comparison of Vpu sequences from diverse geographical isolates of HIV type 1 identifies the presence of highly variable domains, additional invariant amino acids, and a signature sequence motif common to subtype C isolates, AIDS Res. Hum. Retroviruses, 16, 1089, 10.1089/08892220050075363

McCormick-Davis, 2000, A molecular clone of simian-human immunodeficiency virus (ΔvpuSHIVKU-1bMC33) with a truncated, non-membrane-bound vpu results in rapid CD4+ T cell loss and neuroAIDS in pig-tailed macaques, Virology, 272, 112, 10.1006/viro.2000.0333

Pacyniak, E., Gomez, M.L., Mulcahy, E.R., Jackson, M.J., Hout, D.R., Wisdom, B.J., Stephens, E.B., in press. Identification of a region within the cytoplasmic domain of the subtype B Vpu protein of human immunodeficiency virus type 1 (HIV-1) that is responsible for retention in the Golgi complex and its absence in the Vpu protein from subtype C HIV-1. AIDS Res. Hum. Retro.

Park, 2003, Three-dimensional structure of the channel-forming trans-membrane domain of virus protein “u” (Vpu) from HIV-1, J. Mol. Biol., 333, 409, 10.1016/j.jmb.2003.08.048

Paul, 1997, Phosphorylation of both phosphoacceptor sites in the HIV-1 Vpu cytoplasmic domain is essential for Vpu-mediated ER degradation of CD4, Virology, 232, 207, 10.1006/viro.1997.8541

Ratner, 1985, Complete nucleotide sequence of the AIDS virus, HTLV-III, Nature, 313, 277, 10.1038/313277a0

Regier, 1990, The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus, AIDS Res. Hum. Retroviruses, 6, 1221, 10.1089/aid.1990.6.1221

Reimann, 1996, An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys, J. Virol., 70, 3198, 10.1128/JVI.70.5.3198-3206.1996

Schubert, 1994, The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif, J. Mol. Biol., 236, 16, 10.1006/jmbi.1994.1114

Schubert, 1996, Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells, FEBS Lett., 398, 12, 10.1016/S0014-5793(96)01146-5

Schubert, 1996, The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains, J. Virol., 70, 809, 10.1128/JVI.70.2.809-819.1996

Schubert, 1998, CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway, J. Virol., 72, 2280, 10.1128/JVI.72.3.2280-2288.1998

Sharkey, 2001, Two long terminal repeat circles and persistent HIV-1 replication, Curr. Opin. Infect. Dis., 14, 5, 10.1097/00001432-200102000-00002

Sharkey, 2000, Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy, Nat. Med., 6, 76, 10.1038/71569

Singh, 2001, A simian human immunodeficiency virus with a nonfunctional Vpu (vpuSHIVKU-1bMC33) isolated from a macaque with neuroAIDS has selected for mutations in env and nef that contributed to its pathogenic phenotype, Virology, 282, 123, 10.1006/viro.2000.0821

Singh, 2003, The presence of the casein kinase II phosphorylation sites of Vpu enhances the CD4+ T cell loss caused by the simian-human immunodeficiency virus SHIVKU-lbMC33 in pig-tailed macaques, Virology, 313, 435, 10.1016/S0042-6822(03)00339-8

Stephens, 1998, Nucleotide substitutions in the long terminal repeat are not required for development of neurovirulence by simian immunodeficiency virus strain mac, J. Gen. Virol., 79, 1089, 10.1099/0022-1317-79-5-1089

Stephens, 2002, Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques, Virology, 293, 252, 10.1006/viro.2001.1244

Teo, 1997, Circular forms of unintegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS, J. Virol., 71, 2928, 10.1128/JVI.71.4.2928-2933.1997

Tiganos, 1998, Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 Vpu protein, Virology, 251, 96, 10.1006/viro.1998.9368

Varthakavi, 2003, Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production, Proc. Natl. Acad. Sci. U.S.A., 100, 15154, 10.1073/pnas.2433165100

Zazzi, 1997, Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression, J. Med. Virol., 52, 20, 10.1002/(SICI)1096-9071(199705)52:1<20::AID-JMV4>3.0.CO;2-T